BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33663332)

  • 1. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism.
    Qin X; Wang B; Li B; Lin C; Liu X; Xie X
    Ren Fail; 2021 Dec; 43(1):445-451. PubMed ID: 33663332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease.
    Peng C; Zhang Z; Liu J; Chen H; Tu X; Hu R; Ni J; Weng N; Pang H; Xue Z
    Head Neck; 2017 Mar; 39(3):564-571. PubMed ID: 28032671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.
    Zeng Z; Peng CZ; Liu JB; Li YW; He HF; Hu QH; Lin B; Shen XG
    Sci Rep; 2020 Apr; 10(1):6206. PubMed ID: 32277134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.
    Zhang X; Xu W; Huang T; Huang J; Zhang C; Zhang Y; Xie X; Xu M
    Ren Fail; 2022 Dec; 44(1):146-154. PubMed ID: 35164637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
    Qiu X; Gao M; Zhang D; Ji F
    Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience.
    Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Li D; Yue W; Peng C; Xu HX
    Endocrine; 2024 Mar; 83(3):681-690. PubMed ID: 37725290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Study on Safety and Efficacy of Microwave Ablation for Primary Hyperparathyroidism.
    Wei Y; Peng L; Li Y; Zhao ZL; Yu MA
    Korean J Radiol; 2020 May; 21(5):572-581. PubMed ID: 32323502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics.
    Ha EJ; Baek JH; Baek SM
    Korean J Radiol; 2020 Dec; 21(12):1383-1392. PubMed ID: 32767864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation.
    Yue W; Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Xu D; Peng C
    Int J Hyperthermia; 2023; 40(1):2223370. PubMed ID: 37344379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.
    Yamamoto M; Ogata H; Mizobuchi M; Yoshida N; Kumata-Maeta C; Koiwa F; Shishido K; Kinugasa E
    Clin Exp Nephrol; 2012 Apr; 16(2):292-9. PubMed ID: 22011886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exploration on total parathyroidectomy for secondary hyperparathyroidism].
    Yang XQ; Chen AJ; Wang TT; Xu XF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):98-103. PubMed ID: 32074746
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study.
    Chen CC; Chen HL; Chiang PL; Luo SD; Chang YH; Chen WC; Wang CK; Lin AN; Chen YS; Chi SY; Lin WC
    Int J Hyperthermia; 2022; 39(1):907-917. PubMed ID: 35848429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study.
    Ren M; Zheng D; Wu J; Liu Y; Peng C; Shen W; Lin B
    Sci Rep; 2022 Jun; 12(1):10289. PubMed ID: 35717444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study.
    Li X; Wei Y; Shao H; Peng L; An C; Yu MA
    Int J Hyperthermia; 2019; 36(1):647-653. PubMed ID: 31305184
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrasound-Guided Radiofrequency Ablation for the Treatment of Primary Hyperparathyroidism: An Efficacy and Safety Study.
    Li X; Tufano RP; Russell JO; Yan L; Xiao J; Li Y; Zhang M; Luo Y
    Endocr Pract; 2021 Dec; 27(12):1205-1211. PubMed ID: 34311118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection.
    Zhuo L; Zhang L; Peng LL; Yang Y; Lu HT; Chen DP; Li WG; Yu MA
    Int J Hyperthermia; 2019; 36(1):29-35. PubMed ID: 30845851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.
    Peng CZ; Chai HH; Zhang ZX; Hu QH; Zeng Z; Cui AL; Pang HS; Ruan LT
    Int J Hyperthermia; 2022; 39(1):490-496. PubMed ID: 35285391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
    Koiwa F; Kakuta T; Tanaka R; Yumita S
    Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.
    Nakai K; Fujii H; Kono K; Goto S; Miura S; Maeda A; Takeda K; Nishi S
    Ther Apher Dial; 2013 Feb; 17(1):24-9. PubMed ID: 23379489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study.
    Deng E; Jiang T; Chai H; Weng N; He H; Zhang Z; Peng C; Yue W; Xu H
    Korean J Radiol; 2024 Mar; 25(3):289-300. PubMed ID: 38413113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.